NSE Momentum: Cipla, Ashok Leyland, Lupin Turn Bullish
NSE's Nifty Pharma and Auto sectors see fresh momentum as Cipla (83.2), Ashok Leyland (65.2), and Lupin (62.4) all turned bullish.
- Visit the stock pages: CIPLA, ASHOKLEY, LUPIN
- Sector CNXPHARMA , which ranks #1 for Relative Strength (Altra Sector score of 95.0 with bullish regime.)
In a period where the broader NSE market signals a 'Mixed' texture, indicated by an Altra Market score of 54.2, several individual stocks are showcasing distinct momentum shifts. The Altra Market score assesses overall market breadth by measuring the percentage of stocks trading above key Exponential Moving Averages (EMAs), offering a read on the market's collective texture. This week, three prominent names—Cipla, Ashok Leyland, and Lupin—have registered significant upgrades in their momentum profiles, moving into bullish territory on the Altra Score. The Altra Score is a proprietary momentum metric, ranging from 0 to 100, derived from the alignment of EMAs and the trend of the Relative Strength Index (RSI) across daily, weekly, and monthly timeframes. A higher score signifies stronger bullish momentum, identifying high-probability setups.
Cipla Ltd.
Cipla, a key player in the Nifty Pharma sector, saw its momentum profile shift dramatically, with its Altra Score jumping from 58.1 (Neutral) to 83.2 (Strong Bullish) on July 28, 2026. This significant move places Cipla firmly in a strong bullish regime, reflecting robust underlying technical strength. The stock is currently trading above its key EMAs, a common indicator of upward price pressure. Its daily RSI stands at 56.74, with weekly RSI at 57.45 and monthly RSI at 51.76, suggesting a balanced but firm momentum across timeframes. Adding to this positive outlook is a bullish Weekly EMA Crossover observed on June 22, 2026, further reinforcing its upward trajectory.
The Nifty Pharma sector itself is demonstrating robust performance, with an Altra Sector score of 95.0, ranking it first among all sectors and indicating a strongly bullish trend. The Altra Sector score applies this same momentum methodology to entire sectors, providing a relative-strength rank against other sectors in the same market, indicating which sectors are leading in momentum. The sector's regime detail describes it as a 'Confirmed leader, accelerating,' with a strong Relative Strength RSI of 70.2, highlighting its superior momentum compared to the broader market. While the overall market environment remains 'Mixed' with only 56.0% of stocks above their 20-day EMA and a 15-day score trend of +16.8, Cipla's individual strength and its sector's leadership stand out.
Ashok Leyland Ltd.
Shifting focus to the Nifty Auto sector, Ashok Leyland has also shown a notable turnaround. On July 28, 2026, its Altra Score climbed from 37.9 (Bearish) to 65.2, signaling a shift to a Bullish momentum regime. This move is particularly interesting given the stock experienced a bearish Weekly EMA Crossover on May 15, 2026. However, the subsequent rise in its Altra Score, driven by the stock now trading above its key EMAs, suggests that other momentum factors have become more dominant, leading to this bullish shift. Its daily RSI is at 54.15, weekly at 48.15, and monthly at 57.67, indicating mixed but improving momentum across different timeframes.
The Nifty Auto sector, though not leading the market like Pharma, still holds a strong position with an Altra Sector score of 71.0, ranking second. Like Pharma, it is characterized as a 'Confirmed leader, accelerating,' with a healthy Relative Strength RSI of 62.7. This indicates that while the broader market presents a 'Mixed' picture, with only 50.0% of stocks above their 50-day EMA, both Cipla and Ashok Leyland are benefiting from strong sectorial tailwinds, even if their individual technical indicators show some historical divergence.
Lupin Ltd.
Returning to the Nifty Pharma sector, Lupin has also marked a significant momentum upgrade, though occurring a day earlier on July 27, 2026. Its Altra Score moved from 43.0 (Neutral) to 64.2 (Bullish), and currently stands at 62.4, maintaining its bullish stance. Similar to Cipla, Lupin is positioned above its key EMAs, which often precedes sustained upward price action. The stock's daily RSI is 47.38, weekly RSI is 58.52, and its monthly RSI is a robust 77.52, pointing to strong long-term momentum. A bullish Weekly EMA Crossover was noted back on November 14, 2025, suggesting that the recent score upgrade is a continuation of an established positive trend.
As a member of the top-ranked Nifty Pharma sector (Altra Sector score 95.0), Lupin is supported by strong industry momentum, described as a 'Confirmed leader, accelerating' with a Relative Strength RSI of 70.2. Despite the overall 'Mixed' market texture, marked by 52.0% of stocks above their 200-day EMA and a 30/20 advances/declines ratio, stocks like Lupin are showing individual resilience and sectorial strength. The combined bullish momentum in both Cipla and Lupin highlights the Nifty Pharma sector's current strength, while Ashok Leyland's move indicates that strong sector performance can lift individual stocks even with mixed historical signals.
These recent momentum shifts in Cipla, Ashok Leyland, and Lupin underscore how individual stock and sectorial strengths can emerge even when the broader market exhibits a 'Mixed' sentiment. While the Altra Market score indicates the need for careful position sizing, the robust Altra Scores and strong Altra Sector readings for Nifty Pharma and Nifty Auto highlight specific areas where bullish momentum is currently developing.
What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.
Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.
Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.